Clinical Trial Update: Psilocybin in Cancer Pain Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating psilocybin for cancer-related pain is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Opioid Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yvan Beaussant, MD, MSci | Conditions: Opioid-Related Disorders, Pain Management | Phase 2 | Status: RECRUITING